维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="Klco"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Association Between Mu tation Clearance After Induction Therapy and Outcomes in A cute Myeloid Leukemia 显示文摘	Klco JM Miller CA Griffith M	2015	JAMA2015，314，8：	1
2	Cough sound analy- sis显示文摘	Martinek J Klco P Vrabee M	2013	Acta Medica Martiniana2013，13，1：	1
3	Suppression of tumor growth through disruption of hypoxia-inducible transcription 显示文摘	Kung AL Wang S Klco JM	2000	Nat Med2000，6，12：	1
4	Cough sound analysis 显示文摘	MARTINEK J KLCO P VRABEC M	2013	Acta Medica Martiniana2013，13，1：	1
5	Inhibition of HIF is necessary for tumor suppression by the yon Hippel - Lindau protein 显示文摘	Kondo K Klco J Nakamura E	2002	Cancer Cell2002，1，3：	1
6	Cloning of Z39Ig, a novel gene with immunoglobulin-like domains located on human chromosome X 显示文摘	Langnaese K Colleaux L Klcos D U	2000	Biochim Biophys Acta2000，1492，23：	1
7	Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist显示文摘	Olenyuk BZ Zhang GJ Klco JM	2004	PNAS2004，101，16：	1
8	Livingston DM Suppression of tumor growth through disruption of hypoxia-inducible transcription显示文摘	Kung AL Wang S Klco JM	2000	Nat Med2000，6，12：	1
9	Suppression of tumour growth through disruption of hypoxia-inducible transcription显示文摘	Kung AL Wang S Klco JM	2000	Nat Med2000，6，12：	1
10	Inhibitor of vascular endothelial growth factor with a sequence-specific bypoxia response element antagonist 显示文摘	Olenyuk B Zhang GJ Klco JM	2004	PNAS2004，100，16：	1
11	Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau pmteinl显示文摘	Kondo K Klco J Nakamura E	2002	Cancer Cell2002，1，：	1
12	State of the art in myeloid sarcoma显示文摘	Klco JM Welch JS Nguyen TT Hurley MY Kreisel FH Hassan A		0，，：	1
13	Inhibition of HIF is necessary for tumor suppression by the von Hippel - Lindau protein 显示文摘	Kondo K Klco J Nakamura E	2002	Cancer Cell2002，1，3：	1
14	Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein显示文摘	Keiichi Kondo Jeff Klco Eijiro Nakamura Mirna Lechpammer William G Kaelin	2002	Cancer Cell2002，，3：	1
15	Combination decitabine,arsenic trioxide,and ascorbic acid for the treatment of myelodysplastic syndrome显示文摘	Welch JS Klco JM	2011	Am J Hematol2011，86，9：	1
16	Suppression of tumor growth through disruption of hypoxia-inducible transcription显示文摘	Kung AL Wang S Klco JM	2000	Nat Med2000，6，12：	1
17	Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study显示文摘	Welch JS Klco JM Gao F		Am J Hematol0，86，9：	1
18	Suppression of tumor growth through disruption of hypoxia-inducible transcription 显示文摘	Kung A L Wang S Klco J M	2000	Nat Med2000，6，12：	1
19	Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of my- elodysplastic syndrome and acute myeloid leukemia: A phase I study 显示文摘	Welch JS Klco JM Gao F	2011	Am J Hematol2011，86，9：	1
20	Notch signaling in acute promyelocytic leukemia显示文摘	Grieselhuber NR Klco JM Verdoni AM	2013	Leukemia2013，27，7：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示